Evidence map›Paper›PMID 38661649›Full record

Trial reportHealth psychology : official journal of the Division of Health Psychology, American Psychological Association2024

Predictors of serostatus nondisclosure in mothers living with human immunodeficiency virus receiving a disclosure intervention: Analysis of a randomized clinical trial intervention arm.

William D Marelich, Brandin Ali, Debra A Murphy, Marya T Schulte, Lisa Armistead

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

William D MarelichDepartment of Psychology, California State University, Fullerton.ORCID 0000-0002-1189-0331
Brandin AliDepartment of Psychology, California State University, Fullerton.
Debra A MurphyDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.
Marya T SchulteSemel Institute for Neuroscience and Human Behavior, University of California, Los Angeles.
Lisa ArmisteadDepartment of Psychology, Georgia State University.
California State University, Fullerton · USUniversity of California, Los Angeles · USGeorgia State University · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
1/2-Maternal HIV: Multisite Trial to Assist Disclosure to ChildrenR01MH094148 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCHULTE, MARYA T · 2012 to 2016
$1.9M
2/2-Maternal HIV: Multisite Trial to Assist Disclosure to ChildrenR01MH094233 · NIMH · GEORGIA STATE UNIVERSITY · PI ARMISTEAD, LISA P · 2012 to 2016
$1.1M
NIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MH094148NIMH NIH HHS R01 MH094233
6 · The paper itself

Abstract

objectiveThe current study applied survival analysis to examine factors associated with nondisclosure of human immunodeficiency virus (HIV) serostatus among mothers living with HIV (MLH) who had participated in a cognitive-behavioral intervention to disclose their HIV status to their children.

methodData were utilized from MLH in the intervention arm of the teaching, raising, and communicating with kids (TRACK; Schulte et al., 2021) trial focusing on serostatus disclosure/nondisclosure across four time points (baseline, 3, 9, and 15 months). MLH (

resultsNondisclosure was associated with MLH reporting better physical and mental health, less conflict with their child, better cohesion within their families, and less perceived stigma. MLH reporting better physical functioning were 58% less likely to disclose compared to those reporting physical limitations (hazard ratio [HR] = 0.42). Those reporting lower levels of disclosure self-efficacy were 59% less likely to disclose than those reporting higher levels (HR = 2.47); by 67 weeks into the study, the nondisclosure rate was 56% for those reporting lower self-efficacy compared to 24% for those reporting higher self-efficacy.

conclusionsAddressing the inclination not to disclose when the MLH is feeling healthy may be an aspect to incorporate into future interventions. Furthermore, improving disclosure self-efficacy to a high level appears to be a critical component to intervention success. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Indexed as

HIV SeropositivityMothersSelf DisclosureAdultCaliforniaChildCognitive Behavioral TherapyFemaleGeorgiaHIV InfectionsHumansTruth Disclosure

Identifiers

PMID38661649
PMCPMC11872341
OpenAlexW4395465640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.